GE HealthCare (GEHC) director boosts stake with stock buy and RSU grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GE HealthCare Technologies Inc. director Phoebe L. Yang Watkin reported acquiring additional common stock. On May 8, 2026, she made an open-market purchase of 1,000 shares at a weighted average price of $63.0063 per share. After this trade, she directly held 13,702 shares.
On May 7, 2026, she also received an award of 3,586 restricted stock units. Each unit represents the right to receive one share of GE HealthCare common stock, with 100% of the units vesting on the earlier of the company’s next annual stockholders meeting or May 7, 2027, subject to the plan terms and any deferral elections.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,000 shares ($63,006)
Net Buy
2 txns
Insider
Yang Watkin Phoebe L.
Role
null
Bought
1,000 shs ($63K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.01 per share | 1,000 | $63.0063 | $63K |
| Grant/Award | Common Stock, par value $0.01 per share | 3,586 | $0.00 | -- |
Holdings After Transaction:
Common Stock, par value $0.01 per share — 13,702 shares (Direct, null)
Footnotes (1)
- Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $62.97 to $63.01, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Key Figures
Open-market purchase: 1,000 shares at $63.0063/share
Post-transaction holdings: 13,702 shares
Restricted stock units granted: 3,586 RSUs
+2 more
5 metrics
Open-market purchase
1,000 shares at $63.0063/share
Common Stock purchased on May 8, 2026
Post-transaction holdings
13,702 shares
Direct common stock position after May 8, 2026 trade
Restricted stock units granted
3,586 RSUs
Award on May 7, 2026
RSU vesting date
Earlier of next annual meeting or May 7, 2027
100% vesting condition for RSU award
Purchase price range
$62.97–$63.01/share
Price range for 1,000-share open-market purchase
Key Terms
restricted stock units, weighted average price, Non-Employee Director Compensation and Benefits Plan, grant, award, or other acquisition, +1 more
5 terms
restricted stock units financial
"Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported represents the weighted average price of shares purchased."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Non-Employee Director Compensation and Benefits Plan financial
"in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan."
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
open-market purchase financial
"transaction_action: open-market purchase"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
FAQ
What insider transactions did GEHC director Phoebe L. Yang Watkin report?
She reported one open-market purchase of 1,000 GE HealthCare shares and an award of 3,586 restricted stock units. Both transactions increased her direct holdings, as disclosed in the Form 4 insider filing.
What restricted stock unit grant did the GEHC director receive?
She received 3,586 restricted stock units tied to GE HealthCare common stock. Each unit represents one future share, with vesting conditions based on the next annual meeting or May 7, 2027, under the company’s director compensation plan.
When will the GEHC director’s restricted stock units vest?
All 3,586 restricted stock units will vest 100% on the earlier of GE HealthCare’s next annual stockholders meeting or May 7, 2027. Settlement may be deferred according to her elections under the director compensation plan.